esomeprazole/ASA Fixed Dose Combination (FDC)
Phase 1Completed 0 watching 0 views this week💤 Quiet
33
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Effect of Food
Conditions
Effect of Food, Pharmacokinetics
Trial Timeline
Jun 1, 2010 → Sep 1, 2010
NCT ID
NCT01163630About esomeprazole/ASA Fixed Dose Combination (FDC)
esomeprazole/ASA Fixed Dose Combination (FDC) is a phase 1 stage product being developed by AstraZeneca for Effect of Food. The current trial status is completed. This product is registered under clinical trial identifier NCT01163630. Target conditions include Effect of Food, Pharmacokinetics.
Hype Score Breakdown
Clinical
10
Activity
5
Company
10
Novelty
3
Community
2
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01163630 | Phase 1 | Completed |
Competing Products
20 competing products in Effect of Food